Expert Opinion On Investigational Drugs

期刊发文

• Multiple initiatives to conquer KRAS G12C inhibitor resistance from the perspective of clinical therapy

  Author: Zhang, Junmin; Zhang, Juanhong; Leung, Elaine Lai-Han; Yao, Xiao-Jun

  Journal: EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2023; Vol. 32, Issue 2, pp. 101-106. DOI: 10.1080/13543784.2023.2178419

• Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Gerilimzumab (GB224), a recombinant humanized interleukin-6 monoclonal antibody, in healthy Chinese adults: A randomized controlled dose-escalation study

  Author: Yan, Diqin; Niu, Suping; Hu, Dingyuan; Dong, Wenliang; Sun, Yunjuan; Wang, Qian; Wang, Simin; Gu, Qun; Liu, Gang; Wang, Jiaxue; Chen, Liming; Lv, Jie; Zheng, Qingshan; Song, Haifeng; Fang, Yi

  Journal: EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2023; Vol. 32, Issue 2, pp. 161-170. DOI: 10.1080/13543784.2023.2178894

• Pharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjects

  Author: Wang, Yanli; Xue, Jinling; Su, Zhengjie; Cui, Yingzi; Liu, Guangwen; Yang, Wei; Liu, Zhengzhi; Chen, Jiahui; Ren, Qing; Yu, Shuang; Cheng, Yang; Zhou, Yannan; Wang, Wanhua; Chen, Xuesong; Qu, Dongmei; Deng, Qiaohuan; Zhao, Yicheng; Yang, Haimiao

  Journal: EXPERT OPINION ON INVESTIGATIONAL DRUGS. 2023; Vol. 32, Issue 3, pp. 263-270. DOI: 10.1080/13543784.2023.2179481

• The Jakinibs in systemic lupus erythematosus: progress and prospects.

  Author: Mok CC¹.

  Journal: Expert Opin Investig Drugs. 2019 Jan;28(1):85-92. doi: 10.1080/13543784.2019.1551358. Epub 2018 Nov 26.

• Investigational antiviral therapies for the treatment of influenza.

  Author: Yang J¹, Huang Y¹, Liu S^1,2.

  Journal: Expert Opin Investig Drugs. 2019 May;28(5):481-488. doi: 10.1080/13543784.2019.1606210. Epub 2019 Apr 24.

• An overview of tyrosine kinase inhibitors for the treatment of epithelial ovarian cancer.

  Author: Wang Z, Fu S.

  Journal: Expert Opin Investig Drugs. 2016 Jan;25(1):15-30. doi: 10.1517/13543784.2016.1117071. Epub 2015 Nov 26.

• An overview of new GLP-1 receptor agonists for type 2 diabetes.

  Author: Tomlinson B, Hu M, Zhang Y, Chan P, Liu ZM.

  Journal: Expert Opin Investig Drugs. 2016;25(2):145-58. doi: 10.1517/13543784.2016.1123249. Epub 2015 Dec 17.

• Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development.

  Author: Li Z, Qiu Q, Geng X, Yang J, Huang W, Qian H.

  Journal: Expert Opin Investig Drugs. 2016 Aug;25(8):871-90. doi: 10.1080/13543784.2016.1189530. Epub 2016 May 27.